These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16398764)

  • 1. Hormone therapy and cardiovascular disease: a systematic review and meta-analysis.
    Magliano DJ; Rogers SL; Abramson MJ; Tonkin AM
    BJOG; 2006 Jan; 113(1):5-14. PubMed ID: 16398764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials.
    Lewis JR; Radavelli-Bagatini S; Rejnmark L; Chen JS; Simpson JM; Lappe JM; Mosekilde L; Prentice RL; Prince RL
    J Bone Miner Res; 2015 Jan; 30(1):165-75. PubMed ID: 25042841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
    Gu Y; Han F; Xue M; Wang M; Huang Y
    BMC Womens Health; 2024 Jan; 24(1):60. PubMed ID: 38263123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
    Schierbeck LL; Rejnmark L; Tofteng CL; Stilgren L; Eiken P; Mosekilde L; Køber L; Jensen JE
    BMJ; 2012 Oct; 345():e6409. PubMed ID: 23048011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between hormone replacement therapy and subsequent stroke: a meta-analysis.
    Bath PM; Gray LJ
    BMJ; 2005 Feb; 330(7487):342. PubMed ID: 15640250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise-based rehabilitation for coronary heart disease.
    Jolliffe JA; Rees K; Taylor RS; Thompson D; Oldridge N; Ebrahim S
    Cochrane Database Syst Rev; 2000; (4):CD001800. PubMed ID: 11034729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.
    Bromley SE; de Vries CS; Thomas D; Farmer RD
    Drug Saf; 2005; 28(6):473-93. PubMed ID: 15924502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease.
    Humphrey LL; Chan BK; Sox HC
    Ann Intern Med; 2002 Aug; 137(4):273-84. PubMed ID: 12186518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.
    Bosco C; Bosnyak Z; Malmberg A; Adolfsson J; Keating NL; Van Hemelrijck M
    Eur Urol; 2015 Sep; 68(3):386-96. PubMed ID: 25484142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.
    Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K
    Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis.
    Muka T; Oliver-Williams C; Kunutsor S; Laven JS; Fauser BC; Chowdhury R; Kavousi M; Franco OH
    JAMA Cardiol; 2016 Oct; 1(7):767-776. PubMed ID: 27627190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen plus progestin and the risk of coronary heart disease.
    Manson JE; Hsia J; Johnson KC; Rossouw JE; Assaf AR; Lasser NL; Trevisan M; Black HR; Heckbert SR; Detrano R; Strickland OL; Wong ND; Crouse JR; Stein E; Cushman M;
    N Engl J Med; 2003 Aug; 349(6):523-34. PubMed ID: 12904517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V; Banks E; Reeves G
    Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases.
    Kim JE; Chang JH; Jeong MJ; Choi J; Park J; Baek C; Shin A; Park SM; Kang D; Choi JY
    Sci Rep; 2020 Nov; 10(1):20631. PubMed ID: 33244065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discrepancy between observational studies and randomized trials of menopausal hormone therapy: did expectations shape experience?
    Col NF; Pauker SG
    Ann Intern Med; 2003 Dec; 139(11):923-9. PubMed ID: 14644895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial.
    Cherry N; Gilmour K; Hannaford P; Heagerty A; Khan MA; Kitchener H; McNamee R; Elstein M; Kay C; Seif M; Buckley H;
    Lancet; 2002 Dec 21-28; 360(9350):2001-8. PubMed ID: 12504395
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.